See more : Guizhou Wire Rope Incorporated Company (600992.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Xiamen Kingdomway Group Company (002626.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Xiamen Kingdomway Group Company, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- RespireRx Pharmaceuticals Inc. (RSPI) Income Statement Analysis – Financial Results
- CI Financial Corp. (CIX.TO) Income Statement Analysis – Financial Results
- Owl Rock Capital Corporation (ORCC) Income Statement Analysis – Financial Results
- PT Nusantara Sejahtera Raya Tbk (CNMA.JK) Income Statement Analysis – Financial Results
- Sasquatch Resources Corp. (SASQ.CN) Income Statement Analysis – Financial Results
Xiamen Kingdomway Group Company (002626.SZ)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.kingdomway.com
About Xiamen Kingdomway Group Company
Xiamen Kingdomway Group Company engages in the manufacturing and sale of the nutrition and health resources in China and internationally. It offers a series of raw material products, including coenzyme Q10, Vitamin A, Vitamin D3, microalgae DHA, and plant ARA, as well as provides dietary supplements and sports nutrition products. The company was formerly known as Xiamen Jindawei Vitamin Co., Ltd. Xiamen Kingdomway Group Company was founded in 1997 and is based in Xiamen, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.10B | 3.01B | 3.62B | 3.50B | 3.19B | 2.87B | 2.08B | 1.66B | 1.20B | 838.25M | 670.16M | 675.98M | 577.94M | 536.25M | 367.96M | 344.63M |
| Cost of Revenue | 1.97B | 1.79B | 1.83B | 1.67B | 1.67B | 1.38B | 1.09B | 980.33M | 755.66M | 482.57M | 433.20M | 435.55M | 312.99M | 277.44M | 223.89M | 225.20M |
| Gross Profit | 1.14B | 1.22B | 1.79B | 1.83B | 1.52B | 1.50B | 996.31M | 682.42M | 448.15M | 355.68M | 236.96M | 240.43M | 264.96M | 258.82M | 144.07M | 119.43M |
| Gross Profit Ratio | 36.62% | 40.49% | 49.38% | 52.25% | 47.53% | 52.06% | 47.79% | 41.04% | 37.23% | 42.43% | 35.36% | 35.57% | 45.84% | 48.26% | 39.15% | 34.65% |
| Research & Development | 58.20M | 71.86M | 82.95M | 73.71M | 65.81M | 69.08M | 46.89M | 44.42M | 33.93M | 41.46M | 39.98M | 34.45M | 28.76M | 23.93M | 20.38M | 12.63M |
| General & Administrative | 418.72M | 85.48M | 85.34M | 68.52M | 65.14M | 82.98M | 72.64M | 53.83M | 63.36M | 28.97M | 26.82M | 38.92M | 18.60M | 13.44M | 10.31M | 10.49M |
| Selling & Marketing | 315.12M | 288.75M | 249.65M | 236.49M | 275.71M | 179.25M | 121.97M | 98.17M | 57.00M | 14.22M | 11.63M | 12.23M | 11.83M | 11.06M | 6.55M | 8.72M |
| SG&A | 738.99M | 374.22M | 334.99M | 305.01M | 340.85M | 262.23M | 194.61M | 151.99M | 120.37M | 43.19M | 38.44M | 51.16M | 30.43M | 24.50M | 16.86M | 19.21M |
| Other Expenses | -17.11M | 290.10M | 281.87M | 246.34M | 207.03M | 31.51M | 4.94M | 15.57M | 7.11M | 9.21M | 9.46M | 6.63M | 1.15M | 6.39M | 467.28K | 505.95K |
| Operating Expenses | 780.08M | 736.18M | 699.80M | 625.06M | 613.69M | 525.47M | 383.19M | 328.15M | 302.34M | 150.93M | 129.70M | 132.30M | 99.99M | 84.93M | 65.37M | 59.93M |
| Cost & Expenses | 2.75B | 2.53B | 2.53B | 2.30B | 2.29B | 1.90B | 1.47B | 1.31B | 1.06B | 633.51M | 562.90M | 567.84M | 412.98M | 362.37M | 289.26M | 285.13M |
| Interest Income | 18.54M | 13.21M | 10.88M | 14.67M | 11.22M | 10.15M | 11.93M | 14.81M | 12.54M | 6.85M | 11.44M | 17.52M | 2.55M | 660.15K | 1.07M | 273.54K |
| Interest Expense | 40.29M | 36.90M | 33.67M | 32.70M | 49.99M | 27.80M | 15.80M | 20.19M | 10.57M | 654.15K | 426.76K | 4.06M | 5.83M | 6.76M | 10.29M | 14.31M |
| Depreciation & Amortization | 216.18M | 220.68M | 188.30M | 118.44M | 125.34M | 107.03M | 89.60M | 91.95M | 71.62M | 50.49M | 38.30M | 34.38M | 26.87M | 25.40M | 25.27M | 24.98M |
| EBITDA | 588.78M | 554.84M | 1.14B | 1.29B | 807.65M | 959.90M | 663.55M | 471.10M | 210.55M | 255.44M | 156.89M | 156.31M | 190.97M | 197.26M | 94.88M | 73.96M |
| EBITDA Ratio | 18.98% | 25.17% | 34.55% | 38.29% | 34.28% | 39.84% | 33.33% | 28.46% | 18.44% | 31.09% | 23.71% | 24.45% | 33.06% | 37.79% | 28.18% | 21.78% |
| Operating Income | 355.96M | 550.31M | 937.34M | 1.13B | 974.06M | 802.55M | 559.59M | 349.83M | 124.92M | 223.22M | 110.00M | 111.56M | 157.33M | 159.82M | 62.68M | 34.23M |
| Operating Income Ratio | 11.47% | 18.29% | 25.92% | 32.28% | 30.52% | 27.94% | 26.84% | 21.04% | 10.38% | 26.63% | 16.41% | 16.50% | 27.22% | 29.80% | 17.03% | 9.93% |
| Total Other Income/Expenses | -21.35M | -1.62M | -6.16M | 14.57M | 31.07M | 31.51M | 4.94M | 13.29M | 6.21M | 7.39M | 8.59M | 6.30M | -6.62M | 5.27M | -13.13M | -22.51M |
| Income Before Tax | 334.61M | 310.73M | 931.19M | 1.15B | 611.86M | 834.06M | 564.53M | 363.11M | 131.14M | 230.61M | 118.59M | 117.87M | 158.28M | 165.09M | 59.32M | 34.67M |
| Income Before Tax Ratio | 10.78% | 10.33% | 25.75% | 32.69% | 19.17% | 29.03% | 27.08% | 21.84% | 10.89% | 27.51% | 17.70% | 17.44% | 27.39% | 30.79% | 16.12% | 10.06% |
| Income Tax Expense | 58.42M | 66.17M | 149.32M | 192.30M | 157.99M | 147.90M | 99.50M | 63.05M | 21.16M | 36.38M | 16.68M | 16.17M | 26.15M | 24.99M | 8.81M | 5.94M |
| Net Income | 276.71M | 257.40M | 788.86M | 959.21M | 450.71M | 687.25M | 474.05M | 299.77M | 112.57M | 194.54M | 102.13M | 101.69M | 132.12M | 141.53M | 52.46M | 31.92M |
| Net Income Ratio | 8.92% | 8.55% | 21.81% | 27.37% | 14.12% | 23.92% | 22.74% | 18.03% | 9.35% | 23.21% | 15.24% | 15.04% | 22.86% | 26.39% | 14.26% | 9.26% |
| EPS | 0.45 | 0.42 | 1.29 | 1.57 | 0.74 | 1.11 | 0.77 | 0.51 | 0.20 | 0.34 | 0.18 | 0.18 | 0.29 | 0.33 | 0.12 | 0.08 |
| EPS Diluted | 0.45 | 0.42 | 1.29 | 1.57 | 0.74 | 1.11 | 0.77 | 0.51 | 0.20 | 0.34 | 0.18 | 0.18 | 0.29 | 0.33 | 0.12 | 0.08 |
| Weighted Avg Shares Out | 614.91M | 609.93M | 609.93M | 609.93M | 609.93M | 616.48M | 615.65M | 587.78M | 562.86M | 572.17M | 583.60M | 581.09M | 454.62M | 429.28M | 430.48M | 425.56M |
| Weighted Avg Shares Out (Dil) | 614.91M | 609.93M | 609.93M | 609.93M | 609.93M | 619.15M | 615.65M | 587.78M | 562.86M | 572.17M | 583.60M | 581.09M | 454.62M | 429.28M | 430.48M | 425.56M |
Source: https://incomestatements.info
Category: Stock Reports